Neridronate 是一种氨基二膦酸盐，用于治疗成骨不全症 (OI) 和佩吉特骨病(PDB)。Neridronate 对其他骨骼疾病也有效，如骨质疏松症，骨痛退化症，恶性高钙血症和骨转移病变。
CAS：79778-41-9
分子式：C6H17NO7P2
分子量：277.15
纯度：98%
存储：Store at -20°C

Background:

Neridronate is an aminobisphosphonate, licensed in Italy for the treatment of osteogenesis imperfecta (OI) and Paget’s disease of bone (PDB). Neridronate is effective also in other skeletal diseases such as osteoporosis, algodystrophy, hypercalcemia of malignancy, and bone metastases[1][2].

[1]. Gatti D, et al. Clinical development of neridronate: potential for new applications. Ther Clin Risk Manag. 2013;9:139-47. [2]. Guiducci L, et al. Monthly Intramuscular Neridronate for the Treatment of Postmenopausal Osteoporosis: Results of a 6-Year Prospective Italian Study. Int J Endocrinol. 2019 Feb 6;2019:9802827.